REDUCING THE SIDE EFFECTS
AND NEED FOR STEROID THERAPY
Novel and improved Cannabidiol (CBD)-based treatment solutions,
to reduce the side effects and need for steroid therapy.
STERO Biotechs’ business concept and development plan are based on promising preliminary data from a phase 2 clinical trial in graft versus host disease (GVHD) performed by the founders of STERO, showing that the use of CBD SIGNIFICANTLY REDUCED THE NEED OF STEROID TREATMENT while arresting or curing the disease and its complications.
Furthermore, data from the literature and our own shows that CBD is well tolerated …More Details →
STERO Biotechs aims to solve an unmet need by using Cannabidiol (CBD), a non-psychotropic component of Cannabis sativa, which has been shown to possess potent Immuno-modulatory and anti-inflammatory properties in various indications. Our results in the GVHD trial show that CBD administration enhanced the therapeutic effect of steroids or reduced the steroid dosage while maintaining or improving the steroid’s original therapeutic effect. …More Details→
A patent named CANNABIDIOL FOR REDUCING A STEROID DOSE AND TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES was filed on May 2017 by STERO Biotechs.
The Patent was granted on August 2018
The patent covers the use of CBD for enhancing the therapeutic effect of a steroid or for reducing the dose of a steroid and for reducing side effects associated with the steroid.
Over 130 diseases including …More Details →